Spironolactone for the treatment of melasma: a prospective, open-label proof-of-concept and dose-ranging study Save

Date Added
December 4th, 2018
PRO Number
Pro00076765
Researcher
Dirk Elston

List of Studies


Profiles_link
Keywords
Drug Studies, Skin
Summary

The purpose of this study is to evaluate if the drug spironolactone - which is used to treat acne and male pattern hair growth in women - is effective in treating melasma in females and which dose of the drug works the best. Participation in this study will take about 5 clinic visits over approximately 16 weeks and the option to continue for longer if desired.

Institution
MUSC
Recruitment Contact
Den Lynch
843-876-5074
lynchd@musc.edu

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma Save

Date Added
March 14th, 2017
PRO Number
Pro00063052
Researcher
Dirk Elston

List of Studies


Profiles_link
Keywords
Cancer/Lymphoma, Skin
Summary

The purpose of this study is to test the safety and efficacy (how well the study medication works) of the experimental SGX301 drug in participants with cutaneous T-cell lymphoma in combination with light therapy using standard fluorescent lights.

Institution
MUSC
Recruitment Contact
Adrian Modzik
843-792-8385
cantur@musc.edu

Change_preferences

-- OR --

Create_login